Personalizing a schedule of endoscopic surveillance for patients with low-grade Barrett’s esophagus based on individual risk for disease progression could eliminate the number of people who undergo endoscopies by nearly two-thirds, Dutch researchers have found.
Even so, roughly 7% of patients still could be treated unnecessarily, and progression to high-grade dysplasia or esophageal cancer still could be missed in 1.5% of cases, according to the researchers, who submitted their findings to